Background Pectointercostal Fascial Plane Block (PIFB) targets the anterior cutaneous branches of the intercostal nerves and provides analgesia to the anteromedial chest wall. In this study, we aimed to evaluate the effect of PIFB in addition to Serratus Anterior Plane Block (SAPB) on postoperative morphine consumption and pain scores in breast reduction surgery. Materials and Methods Sixty-four ASA I–II patients (≥18 years) were randomly assigned to two groups. General anesthesia was induced with propofol, rocuronium, fentanyl, and maintained with sevoflurane and remifentanil. After intubation:<UnorderedList Mark="Bullet"> <ItemContent> Group I (PIFB + SAPB) received bilateral PIFB (15 mL 0.25% bupivacaine) and SAPB (20 mL 0.25% bupivacaine). </ItemContent> <ItemContent> Group II (SAPB only) received SAPB (20 mL 0.25% bupivacaine) only. </ItemContent> </UnorderedList> Postoperative analgesia included IV morphine patient-controlled analgesia (1 mg bolus, 10-min lockout, 4-hour limit: 10 mg). Outcomes measured were stay in postanesthesia care unit time (PACU), 24-hour morphine consumption, morphine demands, VAS scores (rest and movement), additional analgesic use, and complications. Results Both groups had similar demographics, surgical duration, and PACU stay. 24-hour morphine consumption was lower in Group I (3.7±2.2 mg vs. 7.9±2.3 mg, p<0.05). Morphine demands were lower in Group I (4.5±2.7 vs. 10.4±3.7, p<0.05). VAS scores (rest and movement) were lower in Group I (p<0.05). Rescue analgesic requirement was lower in Group I than in Group I (p=0.01). No complications occurred in both groups. Conclusion PIFB combined with SAPB significantly reduces morphine consumption and pain scores in breast reduction surgery without complications. Level of Evidence I This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors <a href="http://www.springer.com/00266">www.springer.com/00266</a>.

Enhancing Postoperative Analgesia in Breast Reduction Surgery: The Combined Effect of Pectointercostal Fascial Plane Block and Serratus Anterior Plane Block

期刊论文
发表日期：

2025年8月15日

查看全文

Ayşe İrem Bozkurt,
İbrahim Tabakan,
Feride Karacaer,
Demet Laflı Tunay,
Murat Ilginel,
Ebru Biricik

摘要

Background

Pectointercostal Fascial Plane Block (PIFB) targets the anterior cutaneous branches of the intercostal nerves and provides analgesia to the anteromedial chest wall. In this study, we aimed to evaluate the effect of PIFB in addition to Serratus Anterior Plane Block (SAPB) on postoperative morphine consumption and pain scores in breast reduction surgery.

Materials and Methods

Sixty-four ASA I–II patients (≥18 years) were randomly assigned to two groups. General anesthesia was induced with propofol, rocuronium, fentanyl, and maintained with sevoflurane and remifentanil. After intubation:

Group I (PIFB + SAPB) received bilateral PIFB (15 mL 0.25% bupivacaine) and SAPB (20 mL 0.25% bupivacaine).

Group II (SAPB only) received SAPB (20 mL 0.25% bupivacaine) only.

Postoperative analgesia included IV morphine patient-controlled analgesia (1 mg bolus, 10-min lockout, 4-hour limit: 10 mg). Outcomes measured were stay in postanesthesia care unit time (PACU), 24-hour morphine consumption, morphine demands, VAS scores (rest and movement), additional analgesic use, and complications.

Results

Both groups had similar demographics, surgical duration, and PACU stay. 24-hour morphine consumption was lower in Group I (3.7±2.2 mg vs. 7.9±2.3 mg, p<0.05). Morphine demands were lower in Group I (4.5±2.7 vs. 10.4±3.7, p<0.05). VAS scores (rest and movement) were lower in Group I (p<0.05). Rescue analgesic requirement was lower in Group I than in Group I (p=0.01). No complications occurred in both groups.

Conclusion

PIFB combined with SAPB significantly reduces morphine consumption and pain scores in breast reduction surgery without complications.

Level of Evidence I

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.